Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01646333 · ClinicalTrials.gov registry record · NA

A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease

A NA study of Mild Cognitive Impairment and Parkinson's Disease, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT01646333: Completed NA study of Mild Cognitive Impairment and Parkinson's Disease, sponsored by Virginia Commonwealth University.

NCT01646333 is a NA study of Mild Cognitive Impairment and Parkinson's Disease that has completed, run by Virginia Commonwealth University. The registered enrollment target is 32 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01646333, a NA study of Mild Cognitive Impairment and Parkinson's Disease, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

This randomized, controlled trial (RCT) evaluates the benefits of memory and problem solving training compared to supportive therapy in individuals with Parkinson's Disease with Mild Cognitive Impairment (MCI) and their support persons. Participants will be randomly assigned to receive memory and problem solving training or supportive therapy for 2-months. A 6-month follow up evaluation will establish if benefits remain over time. Impact of these therapies on thinking abilities, physical health, and patient and support person ratings of thinking skills, mood and quality of life will be evaluated. The memory and problem solving training is hypothesized to result in greater improvements and/or stability of function on neuropsychological tests of attention, working memory, learning, and memory skills compared to the supportive therapy condition. Both conditions are hypothesized to result in improved mood and quality of life ratings. Results from this study will determine whether memory and problem solving therapies and supportive therapy are easily used by and beneficial for individuals with Parkinson's Disease and Mild Cognitive Impairment. If positive benefit is observed, information from this study will be used to further optimize these therapies for larger trials designed to evaluate the value of the therapies for individuals with Parkinson's Disease and their support persons.

Primary Outcome

Change in California Verbal Learning Test-II Long Delay Free Recall Scaled Score from Baseline and 10 weeks

Interventions

  • BEHAVIORAL Supportive Therapy
  • BEHAVIORAL Memory and Problem-Solving Intervention

Study Locations (1)

Virginia

  • VCU Parkinson's and Movement Disorders Center - Richmond

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2012-07
Est. Completion 2015-12
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT01646333 record still lists

NCT01646333 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Supportive Therapy is the first listed.

NCT01646333 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT01646333 about?

NCT01646333 is a clinical study titled "A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease". This randomized, controlled trial (RCT) evaluates the benefits of memory and problem solving training compared to supportive therapy in individuals with Parkinson's Disease with Mild Cognitive Impairment (MCI) and their support persons. Participants will be randomly assigned to receive memory and pr...

What is the current status of trial NCT01646333?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2012-07. Estimated completion is 2015-12.

What conditions does trial NCT01646333 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Parkinson's Disease.

What interventions are being tested in trial NCT01646333?

The interventions under investigation include: Supportive Therapy (BEHAVIORAL), Memory and Problem-Solving Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01646333?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01646333 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01646333's enrollment target sits among peer trials

32 163rd of 205 higher than 42 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01646333, the US trial registry maintained by the National Library of Medicine. NCT01646333 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.